NCT02318719View on ClinicalTrials.gov

DS-5565 Phase III Study for Post-herpetic Neuralgia

NACompletedINTERVENTIONAL
Enrollment

765

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 25, 2017

Study Completion Date

May 25, 2017

Conditions
Post-Herpetic Neuralgia
Interventions
DRUG

Placebo

Placebo

DRUG

DS-5565

Trial Locations (1)

870-0942

Medical Corporation Fujigaki Clinic, Ōita

Sponsors
All Listed Sponsors
collaborator

SRL Medisearch Inc.

INDUSTRY

collaborator

Quintiles, Inc.

INDUSTRY

lead

Daiichi Sankyo Co., Ltd.

INDUSTRY